SCHEMBL7027580

SCHEMBL7027580

c1ccc2[nH]c(-c3ncnc4nc[nH]c34)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.47
▸ CDC7 O00311 1/20 0.46
▸ ITK Q08881 6/20 0.46
▸ AKT2 P31751 6/20 0.45
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PRKACA P17612 3/20 0.42
▸ PRKACG P22612 3/20 0.42
▸ PRKACB P22694 3/20 0.42
▸ RET P07949 2/20 0.41
▸ KDR P35968 2/20 0.41
▸ SRC P12931 2/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ GSK3B P49841 1/20 0.40
▸ HTR3E A5X5Y0 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HTR3B O95264 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTR3A P46098 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7027575 0.77 ITK (0.48) ITKNPC1RAB9ARETKDR
SCHEMBL18486291 0.73 AKT2 (0.44) MAPK14CDC7AKT2PRKACAPRKACG
SCHEMBL12638816 0.72 GSK3B (0.45) ITKNPC1RAB9ARETKDR
SCHEMBL3778190 0.72 AKT2 (0.48) MAPK14CDC7AKT2PRKACAPRKACG
SCHEMBL2938675 0.72 AKT2 (0.70) MAPK14CDC7AKT2PRKACAPRKACG
SCHEMBL5179280 0.71 ITK (0.61) ITKNPC1RAB9ARETKDR
SCHEMBL7027583 0.71 MAPT (0.54) MAPK14AKT2MEN1MAPTKMT2A
SCHEMBL18486241 0.70 PIK3CA (0.46) MAPK14CDC7AKT2NPC1RAB9A
SCHEMBL5249228 0.70 GSK3B (0.48) ITKNPC1RAB9ARETKDR
SCHEMBL2396572 0.70 CDK2 (0.44) ITKNPC1RAB9AKDRGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002018404-A9 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C HOFFMANN LA ROCHE (CH) 2003-10-02 — — WO disclosed
EP-1315736-A2 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C F. HOFFMANN-LA ROCHE AG (CH) 2003-06-04 — — EP disclosed
WO-2002018404-A2 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C F. HOFFMANN-LA ROCHE AG (CH) 2002-03-07 — — WO disclosed
Send feedback